{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:21:47Z","timestamp":1793496107753,"version":"4.5.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Uterine fibroids (UF) are the most common benign tumors of the female reproductive system, imposing a significant health burden. A comprehensive understanding of their global, regional, and national burden is essential for targeted public health planning. This study aimed to analyze the spatiotemporal trends of UF burden from 1990 to 2021 and project future trends to 2036.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data on the incidence, prevalence, and disability-adjusted life years (DALYs) of UF from 1990 to 2021 were extracted from the Global Burden of Disease (GBD) 2021 study, covering 204 countries and territories. We analyzed trends using estimated annual percentage changes (EAPC) for age-standardized rates. Socio-demographic Index (SDI) was used to assess the association between development level and disease burden. The Slope Index of Inequality (SII) and concentration index were employed to quantify health inequalities. A Bayesian age-period-cohort (BAPC) model was used to project the burden to 2036.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between 1990 and 2021, the global ASIR of UF rose from 234.36 (95%UI: 171.06, 309.92) to 250.93 (183.44, 330.94) per 100,000 [EAPC 0.24 (0.23, 0.25)]. The ASPR increased from 2799.88 (2133.46, 3650.54) to 2841.07 (2164.43, 3682.27) [EAPC 0.04 (0.03, 0.06)]. DALYs grew from 81,142 (57,125, 111,989) to 142,885 (102,183, 192,988), while ASDR showed little change, from 3.48 (2.46, 4.77) to 3.39 (2.43, 4.59). Regional analysis indicated that South Asia exhibited the highest incidence and prevalence of UF, whereas Oceania and Australia experienced a lower burden. Analysis of health inequality revealed a shift in the burden of UF incidence and prevalence from high to low Socio-Demographic Index (SDI) countries between 1990 and 2021, indicating a reduction in health inequality. Future predictions from the BAPC model indicate that both ASIR and ASPR are expected to continue to rise, while ASDR is likely to decline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>From 1990 to 2021, the global incidence of UF has steadily risen, with South Asia experiencing the greatest impact. Despite the stabilization of ASDR, the rise in ASIR and ASPR remains a significant public health challenge worldwide. Health inequality analysis indicates that the burden of UF is shifting toward low SDI countries. Future prevention and treatment strategies for UF should focus on middle- and low-income countries, specifically by implementing targeted screening programs, investing in low-cost diagnostic tools, and launching public health awareness campaigns. Global public health cooperation, along with early diagnosis and treatment strategies for UF, will be crucial in reducing the disease burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/frph.2025.1629834","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T05:31:19Z","timestamp":1758173479000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The epidemiology of uterine fibroids: global disease burden from 1990 to 2021 and future trend predictions"],"prefix":"10.3389","volume":"7","author":[{"given":"Chan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3390\/nu16060807","article-title":"Empowering strategies for lifestyle interventions, diet modifications, and environmental practices for uterine fibroid prevention; unveiling the LIFE UP awareness","volume":"16","author":"Vafaei","year":"2024","journal-title":"Nutrients"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e244185","DOI":"10.1001\/jamanetworkopen.2024.4185","article-title":"Family history and uterine fibroid development in black and African American women","volume":"7","author":"Langton","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e255235","DOI":"10.1001\/jamanetworkopen.2025.5235","article-title":"Uterine fibroid diagnosis by race and ethnicity in an integrated health care system","volume":"8","author":"Mitro","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bpobgyn.2017.09.007","article-title":"Medical therapy for fibroids: an overview","volume":"46","author":"Sinai Talaulikar","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0187821","DOI":"10.1371\/journal.pone.0187821","article-title":"Adverse obstetric outcomes in pregnant women with uterine fibroids in China: a multicenter survey involving 112,403 deliveries","volume":"12","author":"Zhao","year":"2017","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.fertnstert.2024.02.049","article-title":"Uterine fibroid-related infertility: mechanisms and management","volume":"122","author":"Donnez","year":"2024","journal-title":"Fertil Steril"},{"key":"B7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/humupd\/dmac008","article-title":"Epigenomic and enhancer dysregulation in uterine leiomyomas","volume":"28","author":"Mlodawska","year":"2022","journal-title":"Hum Reprod Update"},{"key":"B8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.fertnstert.2023.01.022","article-title":"Racial disparities in uterine fibroids and endometriosis: a systematic review and application of social, structural, and political context","volume":"119","author":"Katon","year":"2023","journal-title":"Fertil Steril"},{"key":"B9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0140-6736(25)00728-7","article-title":"Current treatment for symptomatic uterine fibroids: available evidence and therapeutic dilemmas","volume":"406","author":"de Smit","year":"2025","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"CD000547","DOI":"10.1002\/14651858.CD000547.pub3","article-title":"Preoperative medical therapy before surgery for uterine fibroids","volume":"4","author":"Puscasiu","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/1754-9485.13455","article-title":"Quality care guidelines for uterine artery embolisation in women with symptomatic uterine fibroids in Australia and New Zealand: according to the AGREE-II checklist and endorsed by the interventional radiology society of Australasia","volume":"66","author":"Clements","year":"2022","journal-title":"J Med Imaging Radiat Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2021.11.018","article-title":"Myomectomy for a large uterine fibroid via mini-laparotomy: a step-by-step video tutorial","volume":"117","author":"Sandrieser","year":"2022","journal-title":"Fertil Steril"},{"key":"B13","doi-asserted-by":"publisher","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajog.2015.03.019","article-title":"The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013","volume":"213","author":"Soliman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1007\/s43032-024-01727-0","article-title":"The annual economic burden of uterine fibroids in the United States (2010 versus 2022): a comparative cost-analysis","volume":"31","author":"Hazimeh","year":"2024","journal-title":"Reprod Sci (Thousand Oaks, Calif)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"392.e1","DOI":"10.1016\/j.ajog.2021.05.005","article-title":"The environment, leiomyomas, latinas, and adiposity study: rationale and design","volume":"226","author":"Manuel","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"591.e1","DOI":"10.1016\/j.ajog.2018.09.039","article-title":"A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014","volume":"219","author":"Yu","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/ije\/dys017","article-title":"Epidemiology in Latin America and the Caribbean: current situation and challenges","volume":"41","author":"Barreto","year":"2012","journal-title":"Int J Epidemiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/ajo.13120","article-title":"Treatment of symptomatic fibroid disease using uterine fibroid embolisation: an Australian perspective","volume":"60","author":"Clements","year":"2020","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1186\/s12889-023-15765-x","article-title":"Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990\u20132019: an age-period-cohort analysis for the global burden of disease 2019 study","volume":"23","author":"Lou","year":"2023","journal-title":"BMC Public Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.5114\/aoms\/171786","article-title":"Global epidemiological characteristics of uterine fibroids","volume":"19","author":"Li","year":"2023","journal-title":"Arch Med Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e246832","DOI":"10.1001\/jamanetworkopen.2024.6832","article-title":"Hypertension, cardiovascular risk factors, and uterine fibroid diagnosis in midlife","volume":"7","author":"Mitro","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-025-01660-y","article-title":"Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021","volume":"18","author":"Li","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12939-020-01327-9","article-title":"Assessing burden, risk factors, and perceived impact of uterine fibroids on women\u2019s lives in rural Haiti: implications for advancing a health equity agenda, a mixed methods study","volume":"20","author":"Millien","year":"2021","journal-title":"Int J Equity Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e943614","DOI":"10.12659\/msm.943614","article-title":"Advancements and emerging therapies in the medical management of uterine fibroids: a comprehensive scoping review","volume":"30","author":"Krzy\u017canowski","year":"2024","journal-title":"Med Sci Monit"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1185\/03007995.2014.982246","article-title":"Contemporary management of uterine fibroids: focus on emerging medical treatments","volume":"31","author":"Singh","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.jacr.2020.03.018","article-title":"Invasive procedural treatments for symptomatic uterine fibroids: a cost analysis","volume":"17","author":"Cronan","year":"2020","journal-title":"J Am Coll Radiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12905-024-02886-7","article-title":"Key drivers of hysterectomy among women of reproductive age in three states in India: comparative evidence from NFHS-4 and NFHS-5","volume":"24","author":"Singh","year":"2024","journal-title":"BMC Women\u2019s Health"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1093\/humrep\/deae162","article-title":"First Australian estimates of incidence and prevalence of uterine fibroids: a data linkage cohort study 2000\u20132022","volume":"39","author":"Wilson","year":"2024","journal-title":"Hum Reprod (Oxford, England)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"9091","DOI":"10.1038\/s41598-023-36313-y","article-title":"Validation of self-report of uterine fibroid diagnosis using a transvaginal ultrasound scan","volume":"13","author":"Adebamowo","year":"2023","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"18926","DOI":"10.1038\/s41598-023-44703-5","article-title":"Population-based study of the reproductive risk factors for transvaginal ultrasound diagnosed uterine fibroids in Nigerian women","volume":"13","author":"Adebamowo","year":"2023","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e052053","DOI":"10.1136\/bmjopen-2021-052053","article-title":"Epidemiology of uterine fibroid in black African women: a systematic scoping review","volume":"12","author":"Morhason-Bello","year":"2022","journal-title":"BMJ Open"},{"key":"B33","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jmig.2019.06.009","article-title":"Case series of reproductive outcomes after laparoscopic radiofrequency ablation of symptomatic myomas","volume":"27","author":"Berman","year":"2020","journal-title":"J Minim Invasive Gynecol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e085622","DOI":"10.1136\/bmjopen-2024-085622","article-title":"Uterine fibroids and black people of African descent globally: a scoping review protocol","volume":"14","author":"Jefferies","year":"2024","journal-title":"BMJ Open"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e078797","DOI":"10.1136\/bmj-2023-078797","article-title":"Endometriosis and uterine fibroids and risk of premature mortality: prospective cohort study","volume":"387","author":"Wang","year":"2024","journal-title":"Br Med J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"94.e1","DOI":"10.1016\/j.ajog.2020.01.016","article-title":"Adenomyosis incidence, prevalence and treatment: United States population-based study 2006\u20132015","volume":"223","author":"Yu","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ajog.2020.11.014","article-title":"The importance of shared decision making and patient preferences in uterine fibroid treatment outcomes research","volume":"224","author":"Engel","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"403.e1","DOI":"10.1016\/j.ajog.2021.05.033","article-title":"Clinical investigation of fertility after uterine artery embolization","volume":"225","author":"Serres-Cousine","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"826.e1","DOI":"10.1016\/j.ajog.2022.01.022","article-title":"Minimally invasive myomectomy: practice trends and differences between black and non-black women within a large integrated healthcare system","volume":"226","author":"Zaritsky","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41586-021-03747-1","article-title":"Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma","volume":"596","author":"Berta","year":"2021","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1152\/physrev.00010.2024","article-title":"Uterine fibroids","volume":"105","author":"Bulun","year":"2025","journal-title":"Physiol Rev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1210\/endrev\/bnab039","article-title":"Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment","volume":"43","author":"Yang","year":"2022","journal-title":"Endocr Rev"}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2025.1629834\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T05:31:20Z","timestamp":1758173480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2025.1629834\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":42,"alternative-id":["10.3389\/frph.2025.1629834"],"URL":"https:\/\/doi.org\/10.3389\/frph.2025.1629834","relation":{},"ISSN":["2673-3153"],"issn-type":[{"value":"2673-3153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"article-number":"1629834"}}